Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2019, Vol. 39 Issue (8): 40-51    DOI: 10.13523/j.cb.20190806
技术与方法     
抗p185 erb B2人鼠嵌合抗体ChAb26转基因小鼠乳腺生物反应器的制备与验证 *
梁振鑫1,刘芳2,张玮1,刘庆友2,李力1,**()
1 广西医科大学附属肿瘤医院区域性高发肿瘤早期防治研究教育部重点室验室 南宁 530021
2 广西大学动物科学技术学院 南宁 530004
The Preparation and Validation of p185 erb B2 Human-mouse Chimeric Antibody ChAb26 Transgenic Mice Mammary Gl and Bioreactor
LIANG Zhen-xin1,LIU Fang2,ZHANG wei1,LIU Qing-you2,LI Li1,**()
1 Affiliated Tumor Hospital of Guangxi Medical University,Regional High-Defense Tumor Early Prevention Research Department Key Laboratory of Ministry of Education ,Nanning 530021,China
2 College of Animal Science and Technology, Guangxi University, Nanning 530004, China
 全文: PDF(2681 KB)   HTML
摘要:

目的: 构建抗p185 erb B2人鼠嵌合抗体ChAb26转基因动物乳腺特异性表达载体并制备和验证抗p185 erb B2人鼠嵌合抗体ChAb26转基因小鼠乳腺生物反应器模型。方法: 利用PCR法扩增出抗人p185 erb B2人鼠嵌合抗体ChAb26的重链基因H和轻链基因L,然后分别将嵌合抗体重链基因H和嵌合抗体轻链基因L连接到乳腺特异性表达质粒pBC1,从而构建抗p185 erb B2人鼠嵌合抗体ChAb26转基因动物乳腺特异性表达载体pBC1-H和pBC1-L。分别将抗p185 erb B2人鼠嵌合抗体ChAb26乳腺特异表达载体pBC1-H和pBC1-L线性化,然后使用原核显微共注射法获得8只转基因FVB小鼠,通过鼠尾直接PCR鉴定其转基因阳性。通过RT-PCR、荧光定量PCR鉴定转基因小鼠乳腺组织中抗p185 erb B2人鼠嵌合抗体ChAb26的mRNA表达。使用小鼠乳汁采集器收集其乳汁并通过Western blot和夹心ELISA等实验鉴定抗p185 erb B2人鼠嵌合抗体ChAb26是否获得表达。结果: 经测序验证,抗p185 erb B2人鼠嵌合抗体ChAb26的嵌合重链基因H和嵌合轻链基因L分别与乳腺特异表达质粒pBC1正确正向连接。鼠尾直接PCR结果显示所获8只转基因FVB小鼠均为转基因双阳性小鼠,且抗p185 erb B2人鼠嵌合抗体ChAb26的重链基因H和轻链基因L在它们的后代中稳定遗传,它们的后代中转基因小鼠双阳性率约为30%;RT-PCR和荧光定量PCR的结果显示,转基因双阳性小鼠及其双阳性后代的乳腺组织中存在抗p185 erb B2人鼠嵌合抗体ChAb26的mRNA表达;Western blot和ELISA等实验结果显示,转基因双阳性小鼠乳汁中存在抗p185 erb B2人鼠嵌合抗体ChAb26的蛋白质表达,而且抗p185 erb B2人鼠嵌合抗体ChAb26与羊抗人κ链抗体和羊抗人IgG Fc-HRP抗体均能特异性结合。结论: 成功构建抗p185 erb B2人鼠嵌合抗体ChAb26转基因动物乳腺特异性表达载体pBC1-H和pBC1-L和制备了抗p185 erb B2人鼠嵌合抗体ChAb26转基因小鼠乳腺生物反应器模型,为今后抗p185 erb B2人鼠嵌合抗体ChAb26转基因牛乳腺生物反应器的研究奠定了理论和技术基础。

关键词: erbB2原癌基因嵌合抗体转基因小鼠乳腺生物反应器    
Abstract:

Objective: To construct the vectors of human-mouse chimeric antibody ChAb26 with anti-p185, which can be expression in transgenic mice mammary gland and to express the human-mouse chimeric antibody ChAb26 with anti- p185 by mammary gland bioreactor of transgenic mice. Methods: Firstly, to obtain heavy chain gene H and light chain gene L of human-mouse chimeric ChAb26 by PCR. Secondly, the heavy chain gene H and the light chain gene L of human-mouse chimeric antibody ChAb26 connection to pBC1 after their serial numbers are true by DNA sequencing technology proved. Finally, using DNA sequencing technology for detection the vectors of human-mouse chimeric antibody ChAb26 with anti-p185, pBC1-H and pBC1-L and firstly, the pBC1-H plasmid and pBC1-L plasmid to be linearized by SalI and NotI.After,they become the pBC1-H-linear plasmid and pBC1-L-linear plasmid. Secondly,the pBC1-H-linear plasmid and pBC1-L-linear plasmid to be co-injectioned into the fertilized eggs of FVB mice by microinjection. Thirdly,using mouse tail direct PCR kit for detection the positive clones of the founder mice and their descendants.Furthermore,using RT-PCR and real-time PCR technique for detection the express mRNA of the human-mouse chimeric antibody ChAb26 in transgenic mice mammary gland.The last,using ELISA and Western blot technique for detection the express of mRNA of the human-mouse chimeric antibody ChAb26 in transgenic mice mammary gland. Results: Sequence analysis showed that the serial numbers of pBC1-H plasmid and pBC1-L plasmid are true.Sequence analysis showed that all of 8 founder mice were the positive clones by mouse tail direct PCR identification.Besides,the positive clones rate of their descendants average value is 30%,from F1 to F4 generation.Western blot result showed that a 50kDa heavy chain specific band and a 25kDa light chain specific band were observed in milk of transgenic mice,this meaning milk of transgenic mice containthe human-mouse chimeric antibody ChAb26 with anti- p185. ELISA result indicated that the milk of transgenic mice can combine with anti-human IgG (Fc specific)-HRP antibody produced in goat and anti-human Kappa light chain antibody produced in goat,this meaning milk of transgenic mice containthe human-mouse chimeric antibody ChAb26 with anti- p185.RT-PCR and real-time PCR technique result indicated that the express mRNA of the human-mouse chimeric antibody ChAb26 in transgenic mice mammary gland. Conclusion: The anti-p185 erb B2 human mouse chimeric antibody ChAb26 transgenic animal mammary gland specific expression vectors pBC1-H and pBC1-L were successfully constructed and the anti-p185 erb B2 human mouse chimeric antibody ChAb26 transgenic mouse mammary gland bioreactor model was prepared for future anti-p185 erb B2. The human and mouse chimeric antibody ChAb26 transgenic bovine mammary gland bioreactor laid the theoretical and technical basis.

Key words: erbB2 proto-oncogene    Chimeric antibody    Transgenic mouse    Mammary gland bioreactor
收稿日期: 2019-01-22 出版日期: 2019-09-18
ZTFLH:  Q819  
基金资助: *广西科技攻关项目(1598013-2)
通讯作者: 李力     E-mail: lili@gxmu.edu.cn
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
梁振鑫
刘芳
张玮
刘庆友
李力

引用本文:

梁振鑫,刘芳,张玮,刘庆友,李力. 抗p185 erb B2人鼠嵌合抗体ChAb26转基因小鼠乳腺生物反应器的制备与验证 *[J]. 中国生物工程杂志, 2019, 39(8): 40-51.

LIANG Zhen-xin,LIU Fang,ZHANG wei,LIU Qing-you,LI Li. The Preparation and Validation of p185 erb B2 Human-mouse Chimeric Antibody ChAb26 Transgenic Mice Mammary Gl and Bioreactor. China Biotechnology, 2019, 39(8): 40-51.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20190806        https://manu60.magtech.com.cn/biotech/CN/Y2019/V39/I8/40

图1  pSRNC-Cγ1-ZC26和pSRNC-Cκ-ZC26质粒图谱
图2  轻链融合基因信号肽序列及其编码的核苷酸
图3  信号肽分析
图4  抗体ChAb26重链基因H和轻链基因L的PCR产物
图5  pEASY-T1-H重组克隆质粒菌落PCR鉴定
图6  pEASY-T1-L重组克隆质粒菌落PCR鉴定
图7  Xho I酶切克隆质粒pEASY-T1-L电泳图
图8  Xho I酶切克隆质粒pEAS Y-T1-H电泳图
图9  pBC1-H 质粒的菌落PCR鉴定
图10  pBC1-L 质粒的菌落PCR鉴定
图11  乳腺特异性表达载体pBC1-H的线性化策略图
图12  乳腺特异性表达载体pBC1-L的线性化策略图
图13  嵌合抗体轻链基因核苷酸同源性比对分析
图14  嵌合抗体重链基因核苷酸同源性比对分析
图15  鼠尾直接PCR鉴定结果
代 数 小鼠总数(只) 双阳性数量(只) 阳性率(%)
F1
F2
F3
F4
合计
10
21
29
39
99
3
7
9
11
30
30%
33%
31%
28%
30%
表1  F0-1转基因小鼠传代统计表
图16  内参引物的溶解曲线
图17  嵌合抗体的mRNA相对表达量
图18  Western blot 检测嵌合抗体ChAb26的表达
图19  夹心ELISA鉴定嵌合抗体ChAb26的表达
图20  转基因双阳性小鼠乳汁中嵌合抗体的ELISA 定量标准曲线与回归方程
图21  直接ELISA测定嵌合抗体的抗原特异性
图22  直接ELISA测定嵌合抗体的抗原特异性
样品 OD450(xˉ±s) 浓度
(mg/L)
FVB野生型小鼠乳汁 0.203± 0.026
转基因双阳性小鼠(F0-1)乳汁 1.467± 0.013 0.243
转基因双阳性小鼠(F0-2)乳汁 1.488± 0.017 0.248
转基因双阳性小鼠(F0-3)乳汁 1.420± 0.014 0.231
转基因双阳性小鼠(F0-1-F1-1)乳汁 1.420± 0.021 0.233
转基因双阳性小鼠(F0-1-F1-5)乳汁 1.476± 0.015 0.245
转基因双阳性小鼠(F0-1-F2-2)乳汁 1.484± 0.023 0.247
转基因双阳性小鼠(F0-1-F2-4)乳汁 1.432± 0.012 0.234
转基因双阳性小鼠(F0-1-F3-3)乳汁 1.444± 0.019 0.237
平均值 0.240
  
[1] Fanotto V, Ongaro E, Rihawi K , et al. HER-2 inhibition in gastric and colorectal cancers:tangible achievements,novel acquisitions and future perspectives. Oncotarget, 2016,7(42):69060-69074.
[2] Harbeck N . Advances in targeting HER2-positive breast cancer. Curr Opin Obstet Gynecol, 2018,30(1):55-59.
[3] Perrier A, Gligorov J, Lefèvre G , et al. The extracellular domain of Her2 in serum as a biomarker of breast cancer. Lab Invest. 2018,98(6):696-707.
[4] Carvajal-Hausdorf D E, Schalper K A, Bai Y , et al. Objective, domain-specific HER2 measurement in uterine and ovarian serous carcinomas and its clinical significance. Gynecol Oncol, 2017,145(1):154-158.
[5] Marano L, Roviello F . The distinctive nature of HER2-positive gastric cancers. Eur J Surg Oncol, 2015,41(3):271-273.
[6] Wang Y, Zhang S J, Wu F Y , et al. Outcomes of pemetrexed-based chemotherapies in HER2-mutant lung cancers. BMC Cancer, 2018,18(1):326.
[7] Abdel Azim S, Sprung S, Mutz-Dehbalaie I , et al. L1cam and her2 expression in early endometrioid uterine cancer. Int J Gynecol Pathol, 2017,36(4):356-363.
[8] Hosseini H, Obradovi? M M, Hoffmann M , et al. Early dissemination seeds metastasis in breast cancer . Nature, 2016 , 640(7634):20785.
[9] Harper K L, Sosa M S, Entenberg D , et al. Mechanism of early dissemination and metastasis in Her2+ mammary cancer. Nature, 2016,640(7634):20609.
[10] Linde N, Casanova-Acebes M, Sosa M S , et al. Macrophages orchestrate breast cancer early dissemination and metastasis. Nat Commun, 2018,9(1):21.
[11] Stern D F, Heffernan P A, Weinberg R A . P185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Mol Cell Biol, 1986,6(5):1729-1740.
[12] Loibl S, Gianni L . HER2-positive breast cancer. Lancet, 2017,389(10087):2415-2429.
[13] Yanli W, Sihai Z, Liang B , et al. Expression systems and species used for transgenic animal bioreactors. Biomed Res Int, 2013,2013:580463-580469.
[14] Monzani P S, Adona P R, Ohashi O M . Transgenic bovine as bioreactors:Challenges and perspectives. Bioengineered, 2016 , 7(3):123-131.
[15] Ma T, Tao J, Yang M , et al. An AANAT/ASMT transgenic animal model constructed with CRISPR/Cas9 system serving as the mammary gland bioreactor to produce melatonin-enriched milk in sheep. J Pineal Res, 2017,63(1):e12406.
[1] 韩明明,罗玉萍. 内源CD133 +细胞示踪小鼠模型的制备和鉴定 *[J]. 中国生物工程杂志, 2018, 38(6): 58-62.
[2] 葛林, 刘新宇, WANG Guirong. 人SP-B蛋白转基因小鼠及细菌性肺炎模型的构建[J]. 中国生物工程杂志, 2017, 37(10): 65-71.
[3] 左志宇, 辛灵彪, 杨洁, 王鑫廷. SND1转基因小鼠的构建[J]. 中国生物工程杂志, 2016, 36(4): 97-103.
[4] 梁振鑫, 尹富强, 刘庆友, 李力. 转基因动物乳腺生物反应器相关技术及研究进展[J]. 中国生物工程杂志, 2015, 35(2): 92-98.
[5] 易学瑞, 袁有成, 龚亮, 张欣蕊, 李娜, 孔祥平. 8种天然药物与硼替佐米对HBsAg抑制作用及蛋白质组学分析[J]. 中国生物工程杂志, 2015, 35(11): 29-35.
[6] 汤俊明, 赵彦平, 刘奇, 盛青松, 吴黎明, 乔国洪. 构建皮肤组织中特异表达HPV16-E6基因的小鼠模型[J]. 中国生物工程杂志, 2015, 35(10): 27-31.
[7] 秦瑶, 赵鸿彦, 张文航, 王冬梅. 线粒体转录因子A敲低转基因小鼠的研制[J]. 中国生物工程杂志, 2014, 34(7): 44-48.
[8] 张斯敏, 高越, 方彧聃, 张金脉, 张敬之. 乳腺生物反应器特异高效表达载体的构建[J]. 中国生物工程杂志, 2014, 34(7): 49-55.
[9] 王金胜, 姜浩武, 张晋霞, 潘磊, 赵凤芝, 于云飞, 蔡亚雄, 邓宁. 抗FGF2人鼠嵌合抗体在HEK293T细胞中的表达优化[J]. 中国生物工程杂志, 2014, 34(5): 14-22.
[10] 闫亚彬, 蔡勤, 蔡琳琳, 龚秀丽, 朱怡文, 管翌华, 黄英. 比较牛催乳素与生长激素对外源基因表达的影响[J]. 中国生物工程杂志, 2013, 33(8): 91-97.
[11] 蒋世忠, 闫亚彬, 谢飞, 龚秀丽, 黄英, 吕宝忠. 转基因小鼠乳腺上皮细胞的体外培养及其对催乳素反应的研究[J]. 中国生物工程杂志, 2012, 32(03): 20-24.
[12] 马纪, 孙奋勇, 张越, 洪岸. miR-122过表达转基因小鼠质粒构建及其功能验证[J]. 中国生物工程杂志, 2011, 31(9): 28-34.
[13] 李由, 张焱, 苏海佳, 罗坚, 白倩, 马光辉, 苏志国. 乳腺生物反应器表达的重组人乳清白蛋白的高效分离纯化[J]. 中国生物工程杂志, 2011, 31(8): 66-72.
[14] 张景锋, 郭欣政, 卫恒习, 李莉, 张守全. Tet system的调控原理及其在转基因小鼠模型上的应用[J]. 中国生物工程杂志, 2011, 31(11): 90-94.
[15] 郭虹敏 吴晓洁 李想 周艳荣 林艳丽 熊福银 薛世伟 陈红星 陈树林. 表达乙肝病毒受体人ASGPR转基因小鼠的建立[J]. 中国生物工程杂志, 2010, 30(05): 87-91.